Dr. Ross Camidge, University of Colorado Cancer Center (IMAGE)

University of Colorado Anschutz

Dr. Ross Camidge, University of Colorado Cancer Center

Caption

Ross Camidge, M.D., Ph.D., director of the thoracic oncology clinical program at the CU Cancer Center is principal investigator of clinical trial testing ponatinib against FGFR+ lung cancer.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.